Evidence following guidelines: Another COVID-19 paradox.
作者信息
Heymann Warren R
机构信息
Cooper Medical School of Rowan University, Marlton, New Jersey.
出版信息
J Am Acad Dermatol. 2021 Jan;84(1):37-38. doi: 10.1016/j.jaad.2020.10.070. Epub 2020 Oct 29.
Abstract
摘要
相似文献
1
Evidence following guidelines: Another COVID-19 paradox.遵循指南的证据：另一个新冠疫情悖论。
J Am Acad Dermatol. 2021 Jan;84(1):37-38. doi: 10.1016/j.jaad.2020.10.070. Epub 2020 Oct 29.
2
COVID, Biologics, and Psoriasis Therapy.新冠病毒、生物制剂与银屑病治疗
J Am Acad Dermatol. 2020 Dec;83(6):1577-1578. doi: 10.1016/j.jaad.2020.09.005. Epub 2020 Sep 10.
3
Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?慢性炎症性皮肤病与生物制剂：新冠疫情大流行之后的展望？
Int J Dermatol. 2020 Sep;59(9):1144-1145. doi: 10.1111/ijd.15059. Epub 2020 Jul 25.
4
Biological therapies, asthma and coronavirus disease 2019.生物疗法、哮喘与 2019 年冠状病毒病。
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):597-601. doi: 10.1097/ACI.0000000000000783.
5
Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.COVID-19 大流行期间皮肤科治疗药物的感染风险：基于证据的重新调整。
Int J Dermatol. 2020 Sep;59(9):1043-1056. doi: 10.1111/ijd.15028. Epub 2020 Jul 3.
6
Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations.接受生物制剂和某些其他全身治疗的皮肤科患者应接种一剂信使核糖核酸新冠病毒“加强针”疫苗：对美国食品药品监督管理局和免疫实践咨询委员会近期建议的批判性评估
J Am Acad Dermatol. 2021 Nov;85(5):1113-1116. doi: 10.1016/j.jaad.2021.08.031. Epub 2021 Aug 23.
7
Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic.在2019冠状病毒病大流行期间，对接受全身免疫抑制治疗或生物治疗或两者兼有的皮肤科患者进行管理的临床考量。
J Am Acad Dermatol. 2020 Jul;83(1):288-292. doi: 10.1016/j.jaad.2020.04.143. Epub 2020 May 4.
8
Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic.COVID-19大流行期间皮肤科患者生物制剂的持续使用和停用率
J Cutan Med Surg. 2021 Nov-Dec;25(6):646-647. doi: 10.1177/12034754211024125. Epub 2021 Jun 9.
9
COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.新型冠状病毒肺炎与银屑病生物制剂：高流行地区的经验——意大利伦巴第大区贝加莫市
J Am Acad Dermatol. 2020 Jul;83(1):292-294. doi: 10.1016/j.jaad.2020.04.165. Epub 2020 May 6.
10
Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.患有特定皮肤疾病且受 COVID-19 影响的患者：管理策略的经验有何说法？系统评价。
Dermatol Ther. 2020 Nov;33(6):e13867. doi: 10.1111/dth.13867. Epub 2020 Jul 7.
引用本文的文献
1
COVID-19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study.接受免疫抑制/免疫调节治疗患者的新型冠状病毒肺炎感染风险：一项单中心研究
Dermatol Ther. 2021 Nov;34(6):e15126. doi: 10.1111/dth.15126. Epub 2021 Sep 19.
本文引用的文献
1
Covid-19 pandemic and the skin.新冠疫情与皮肤。
Int J Dermatol. 2020 Nov;59(11):1312-1319. doi: 10.1111/ijd.15189. Epub 2020 Sep 21.
2
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.COVID-19 患者使用肿瘤坏死因子抑制剂或甲氨蝶呤的临床结局：一项多中心研究网络研究。
J Am Acad Dermatol. 2021 Jan;84(1):70-75. doi: 10.1016/j.jaad.2020.09.009. Epub 2020 Sep 11.
3
Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries.探讨 COVID-19 期间生物制剂和其他全身治疗药物使用建议：对现有皮肤科指南和患者登记处的回顾和比较。
J Dermatolog Treat. 2022 May;33(3):1208-1212. doi: 10.1080/09546634.2020.1808154. Epub 2020 Oct 30.
4
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.免疫介导性炎症疾病中的新冠病毒病——来自纽约的病例系列
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
5
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.2019年冠状病毒病大流行对接受生物疗法治疗的慢性斑块状银屑病患者的影响：意大利北部的经验。
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
Zotero 插件